Anchor Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 37 Long Wharf Mall, Newport, RI 02840 Phone: 401-846-4404 |
Nathan W. Tilman, Dds, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 136 Broadway, Newport, RI 02840 Phone: 401-846-3801 Fax: 404-184-6384 |
Newport Dental Associates P.c. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 11 Catherine St Unit D, Newport, RI 02840 Phone: 401-474-1613 |
Newport Pediatric Dentistry Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 15 Old Beach Rd, Newport, RI 02840 Phone: 401-849-4790 |
News Archive
Pharmavite LLC, the makers of Nature Made vitamins, minerals and supplements, announced the publication of a review paper in the May issue of the journal Nutrients, highlighting current research into the roles of choline and docosahexaenoic acid in maternal and infant nutrition.
Clinical trial results published in the New England Journal of Medicine this week offer additional evidence that a new device may help relieve chronic heartburn symptoms that standard treatment cannot. The Keck Medical Center of USC was one of 14 U.S. and European medical centers to test the device prior to its March 2012 approval by the U.S. Food and Drug Administration.
WuXi PharmaTech, a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that it had been selected for the Deloitte Technology Fast 500 Asia Pacific 2009 List, the only company in China to receive this award for the past six years. The Deloitte program recognizes technology companies in the Asia Pacific region that have achieved the highest rates of revenue growth during the preceding three years.
The free new mobile app allows engineers and instrumentation professionals to convert between concentration and conductivity. It is available from the App Store, Google Play and MT.com.
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
› Verified 8 days ago